Scedosporium species infections and treatments (Q35622016)

9 August 2017

1 reference

title

Scedosporium species infections and treatments (English)

1 reference

9 August 2017

Steinbach WJ

1

1 reference

PubMed ID

14708963

9 August 2017

Perfect JR

series ordinal

2

1 reference

9 August 2017

1 November 2003

1 reference

9 August 2017

Journal of Chemotherapy

1 reference

9 August 2017

15 Suppl 2

1 reference

9 August 2017

16-27

1 reference

Emerging fungal pathogens: evolving challenges to immunocompromised patients for the twenty-first century

9 August 2017

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

Life History of an Undescribed Ascomycete Isolated from a Granular Mycetoma of Man

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

Pathology of hyalohyphomycosis caused by Scedosporium apiospermum (Pseudallescheria boydii): an emerging mycosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

Isolation, characterization, and antifungal susceptibility of melanin-deficient mutants of Scedosporium prolificans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

Fatal disseminated infection by Scedosporium inflatum after bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

Potted plants in hospitals as reservoirs of pathogenic fungi

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

Disseminated infection and colonization by Scedosporium prolificans: a review of 18 cases, 1990-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

Typing of Scedosporium apiospermum by multilocus enzyme electrophoresis and random amplification of polymorphic DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

Molecular epidemiology of Scedosporium apiospermum infection determined by PCR amplification of ribosomal intergenic spacer sequences in patients with chronic lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

Genotyping study of Scedosporium apiospermum isolates from patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

Scedosporium inflatum: clinical spectrum of a newly recognized pathogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

In vitro activities of four novel triazoles against Scedosporium spp

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

Fungal malignant otitis externa due to Scedosporium apiospermum

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

Scedosporium apiospermum post-traumatic cranial infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

Corneal co-infection with Scedosporium apiospermum and Acanthamoeba after sewage-contaminated ocular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

Fungal keratitis caused by Scedosporium apiospermum: report of two cases and review of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

Post-traumatic Scedosporium inflatum endophthalmitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

Scedosporium apiospermum chorioretinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

Lymphadenitis caused by Scedosporium apiospermum in an immunocompetent patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

Peritonitis by scedosporium apiospermum in a patient undergoing continuous ambulatory peritoneal dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

Invasive fungal sinusitis due to Scedosporium apiospermum in a patient with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

Scedosporium apiospermum (Pseudallescheria boydii) endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

Scedosporium prolificans osteomyelitis in an immunocompetent child treated with voriconazole and caspofungin, as well as locally applied polyhexamethylene biguanide

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

Scedosporium prolificans infection associated with arthritis and osteomyelitis in a horse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

Pseudallescheria boydii osteoarthritis in a patient with acute lymphoblastic leukemia: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

Vertebral osteomyelitis due to Pseudallescheria boydii.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

Clinical resolution of Scedosporium prolificans fungemia associated with reversal of neutropenia following administration of granulocyte colony-stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

Cutaneous Scedosporium apiospermum infection in an immunocompromised patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

Systemic pseudallescheriasis in a patient with acute myelocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

Disseminated Pseudallescheria boydii (Scedosporium apiospermum) infection in a renal transplant patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

Cutaneous infection due to Scedosporium apiospermum in an immunosuppressed patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

Successful outcome of Scedosporium apiospermum disseminated infection treated with voriconazole in a patient receiving corticosteroid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

Disseminated Scedosporium inflatum infection in a patient with acute myeloblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

Disseminated phaeohyphomycosis: review of an emerging mycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

Clinical significance of Scedosporium apiospermum in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

Cerebral Pseudallescheria mycosis after near-drowning

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

A peptidorhamnomannan from the mycelium of Pseudallescheria boydii is a potential diagnostic antigen of this emerging human pathogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

Comparative in-vitro activity of voriconazole (UK-109,496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

Scedosporium infection in immunocompromised patients: successful use of liposomal amphotericin B and itraconazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

Comparative in vitro antifungal activity of amphotericin B lipid complex, amphotericin B and fluconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

Amphotericin B responsive Scedosporium apiospermum infection in a patient with acute myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

In vitro interaction of terbinafine with itraconazole against clinical isolates of Scedosporium prolificans

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

Activities of amphotericin B and antifungal azoles alone and in combination against Pseudallescheria boydii

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

In vitro synergistic interaction between amphotericin B and pentamidine against Scedosporium prolificans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

Amphotericin B lipid complex exerts additive antifungal activity in combination with polymorphonuclear leucocytes against Scedosporium prolificans and Scedosporium apiospermum

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

Human phagocytic cell responses to Scedosporium prolificans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

Antifungal triazoles and polymorphonuclear leukocytes synergize to cause increased hyphal damage to Scedosporium prolificans and Scedosporium apiospermum

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

Liposomal amphotericin B and granulocyte colony-stimulating factor therapy in a murine model of invasive infection by Scedosporium prolificans

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

Successful treatment of simultaneous pulmonary Pseudallescheria boydii and Aspergillus terreus infection with oral itraconazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

Treatment of Scedosporium apiospermum brain abscesses with posaconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

Newer antifungal therapy for emerging fungal pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

In vitro activity of two echinocandin derivatives, LY303366 and MK-0991 (L-743,792), against clinical isolates of Aspergillus, Fusarium, Rhizopus, and other filamentous fungi

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

Invasive pulmonary infection due to Scedosporium apiospermum in two children with chronic granulomatous disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

Pseudallescheria boydii brain abscess successfully treated with voriconazole and surgical drainage: case report and literature review of central nervous system pseudallescheriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

Intramedullary abscess in a patient with disseminated Scedosporium apiospermum infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

Scedosporium apiospermum pneumonia and sternal wound infection in a heart transplant recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

Breakthrough Scedosporium apiospermum (Pseudallescheria boydii) brain abscess during therapy for invasive pulmonary aspergillosis following high-risk allogeneic hematopoietic stem cell transplantation. Scedosporiasis and recent advances in antifunga

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

Disseminated infection due to Scedosporium apiospermum in a patient with acute myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

Oral terbinafine for treatment of pulmonaryPseudallescheria boydii infection refractory to itraconazole therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.SUPPLEMENT-2.16

10.1179/JOC.2003.15.SUPPLEMENT-2.16

21 January 2018

Identifiers

DOI

1 reference

9 August 2017

1 reference

PubMed ID

14708963